These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3088755

  • 21. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 22. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H.
    Thromb Res; 2000 Sep 15; 99(6):623-34. PubMed ID: 10974349
    [Abstract] [Full Text] [Related]

  • 23. Single chain-urokinase binds to oxidized fibrin(ogen) derivatives.
    Stief TW, Martin E, Digon J, Martin-Noya A, Parody R, Rodriguez JM.
    Thromb Res; 1990 Jul 15; 59(2):351-61. PubMed ID: 2122541
    [Abstract] [Full Text] [Related]

  • 24. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N, Kaplan JE.
    Thromb Haemost; 1985 Oct 30; 54(3):639-44. PubMed ID: 2935966
    [Abstract] [Full Text] [Related]

  • 25. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H, Vaheri A.
    Cell Mol Life Sci; 2004 Nov 30; 61(22):2840-58. PubMed ID: 15558213
    [Abstract] [Full Text] [Related]

  • 26. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ, Pring JB, Gaffney PJ.
    Blood Coagul Fibrinolysis; 1992 Aug 30; 3(4):481-3. PubMed ID: 1420825
    [Abstract] [Full Text] [Related]

  • 27. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A, Ling RJ, Sutton PM, Griffiths B, Riley PA, Atkinson T.
    Thromb Haemost; 1985 Apr 22; 53(2):200-3. PubMed ID: 4040659
    [Abstract] [Full Text] [Related]

  • 28. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM, Gilunova NI, Kozhomkulova BZh.
    Lab Delo; 1977 Apr 22; (8):451-4. PubMed ID: 72846
    [No Abstract] [Full Text] [Related]

  • 29. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5899-904. PubMed ID: 8650190
    [Abstract] [Full Text] [Related]

  • 30. [Recent progress in fibrinolytic mechanism].
    Yasukouchi T.
    Rinsho Byori; 1986 Mar 11; 34(3):235-46. PubMed ID: 3086600
    [No Abstract] [Full Text] [Related]

  • 31. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
    Urano T, Takada Y, Takada A.
    Biochim Biophys Acta; 1991 Apr 29; 1077(3):245-52. PubMed ID: 1903067
    [Abstract] [Full Text] [Related]

  • 32. The intrinsic lysis concept.
    Gurewich V, Liu JN, Pannell R.
    Ann N Y Acad Sci; 1992 Dec 04; 667():224-32. PubMed ID: 1309040
    [No Abstract] [Full Text] [Related]

  • 33. Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase.
    Geiger M, Priglinger U, Griffin JH, Binder BR.
    J Biol Chem; 1991 Jun 25; 266(18):11851-7. PubMed ID: 1646816
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S, McMillan E, Doctor V.
    Blood Coagul Fibrinolysis; 2010 Jul 25; 21(5):425-30. PubMed ID: 20445443
    [Abstract] [Full Text] [Related]

  • 35. Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA).
    Kalyan NK, Lee SG, Cheng SM, Hartzell R, Urbano C, Hung PP.
    Gene; 1988 Sep 07; 68(2):205-12. PubMed ID: 3146528
    [Abstract] [Full Text] [Related]

  • 36. The FVII activating protease cleaves single-chain plasminogen activators.
    Römisch J, Vermöhlen S, Feussner A, Stöhr H.
    Haemostasis; 1999 Sep 07; 29(5):292-9. PubMed ID: 10754382
    [Abstract] [Full Text] [Related]

  • 37. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase.
    Marchina E, Barlati S.
    Int J Biochem Cell Biol; 1996 Oct 07; 28(10):1141-50. PubMed ID: 8930138
    [Abstract] [Full Text] [Related]

  • 38. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM.
    J Clin Invest; 1998 Sep 01; 102(5):919-28. PubMed ID: 9727060
    [Abstract] [Full Text] [Related]

  • 39. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ, Kingston IB, Anderson S.
    Anal Biochem; 1995 Apr 10; 226(2):225-31. PubMed ID: 7793622
    [Abstract] [Full Text] [Related]

  • 40. In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions.
    Feng YH, Hart G.
    Cardiovasc Res; 1995 Aug 10; 30(2):255-61. PubMed ID: 7585813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.